DR. MICHAEL WAYNE ORR, DC
Chiropractic at Professional Dr, Gaithersburg, MD
License number
Maryland 01886
Category
Chiropractic
Type
Chiropractor
Address
Address
2
4 Professional Dr STE 139, Gaithersburg, MD 20879
1505 Rosemont Ave, Frederick, MD 21702
1505 Rosemont Ave, Frederick, MD 21702
Phone
(301) 926-2228
(301) 926-3342 (Fax)
(301) 698-8282
(301) 698-8788 (Fax)
(301) 926-3342 (Fax)
(301) 698-8282
(301) 698-8788 (Fax)
Personal information
See more information about MICHAEL WAYNE ORR at radaris.comName
Address
Phone
3500 Princess Caroline Ct, District Hts, MD 20747
335A Chestnut Hill Rd, Forest Hill, MD 21050
922 Luzerne Ave, Baltimore, MD 21205
4763 Cleveland Ln, Andrews Air Force Base, MD 20762
3500 Princess Caroline Ct, District Heights, MD 20747
Professional information
Dr. Michael W Orr, Gaithersburg MD - DC (Doctor of Chiropractic)
Specialties:
Chiropractic
Address:
4 Professional Dr SUITE 139, Gaithersburg 20879
(301) 926-2228 (Phone), (301) 926-3342 (Fax)
(301) 926-2228 (Phone), (301) 926-3342 (Fax)
Languages:
English
Michael Wayne Orr, Gaithersburg MD
Specialties:
Chiropractor
Address:
4 Professional Dr, Gaithersburg, MD 20879
Gene Expression Profiles In Breast Tissue
US Patent:
2007001, Jan 18, 2007
Filed:
Jan 25, 2002
Appl. No.:
10/470050
Inventors:
Michael Orr - Gaithersburg MD, US
MIchelle Nation - Gaithersburg MD, US
James Diggans - Gaithersburg MD, US
Wen Zeng - Gaithersburg MD, US
MIchelle Nation - Gaithersburg MD, US
James Diggans - Gaithersburg MD, US
Wen Zeng - Gaithersburg MD, US
International Classification:
C12Q 1/68, A61K 48/00
US Classification:
435006000, 514044000
Abstract:
The present invention results from the examination of tissue from breast carcinomas to identify genes differentially expressed between tumor biopsies and normal tissue. The invention includes diagnostic and screening methods using these genes as well as solid supports comprising oligonucleotide arrays that are complementary to or hybridize to the differentially expressed genes.
Primary Rat Hepatocyte Toxicity Modeling
US Patent:
2007005, Mar 8, 2007
Filed:
Aug 9, 2004
Appl. No.:
10/515373
Inventors:
Donna Mendrick - Gaithersburg MD, US
Mark Porter - Gaithersburg MD, US
Kory Johnson - Gaithersburg MD, US
Brandon Higgs - Gaithersburg MD, US
Arthur Castle - Gaithersburg MD, US
Michael Orr - Gaithersburg MD, US
Michael Elashoff - Gaithersburg MD, US
Mark Porter - Gaithersburg MD, US
Kory Johnson - Gaithersburg MD, US
Brandon Higgs - Gaithersburg MD, US
Arthur Castle - Gaithersburg MD, US
Michael Orr - Gaithersburg MD, US
Michael Elashoff - Gaithersburg MD, US
Assignee:
Gene Logic Inc. - Gaithersburg MD
International Classification:
G01N 33/50
US Classification:
702019000
Abstract:
The present invention is based on the elucidation of the global changes in gene expression and the identification of toxicity markers in tissues or cells exposed to a known toxin. The genes and their encoded proteins may be used as toxicity markers in drug screening and toxicity assays. The invention also includes a database of genes and/or proteins characterized by toxin-induced differential expression.
Primary Rat Hepatocyte Toxicity Modeling
US Patent:
2009019, Aug 6, 2009
Filed:
Mar 6, 2008
Appl. No.:
12/043666
Inventors:
Donna L. Mendrick - Gaithersburg MD, US
Mark W. Porter - Gaithersburg MD, US
Kory R. Johnson - Gaithersburg MD, US
Brandon Higgs - Gaithersburg MD, US
Arthur L. Castle - Gaithersburg MD, US
Michael Orr - Gaithersburg MD, US
Michael R. Elashoff - Gaithersburg MD, US
Mark W. Porter - Gaithersburg MD, US
Kory R. Johnson - Gaithersburg MD, US
Brandon Higgs - Gaithersburg MD, US
Arthur L. Castle - Gaithersburg MD, US
Michael Orr - Gaithersburg MD, US
Michael R. Elashoff - Gaithersburg MD, US
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
The present invention is based on the elucidation of the global changes in gene expression and the identification of toxicity markers in tissues or cells exposed to a known toxin. The genes may be used as toxicity markers in drug screening and toxicity assays. The invention includes a database of genes characterized by toxin-induced differential expression that is designed for use with microarrays and other solid-phase probes.
Primary Rat Hepatocyte Toxicity Modeling
US Patent:
7469185, Dec 23, 2008
Filed:
Feb 4, 2003
Appl. No.:
10/357507
Inventors:
Donna L. Mendrick - Gaithersburg MD, US
Mark W. Porter - Gaithersburg MD, US
Kory R. Johnson - Gaithersburg MD, US
Brandon Higgs - Gaithersburg MD, US
Arthur L. Castle - Gaithersburg MD, US
Michael Orr - Gaithersburg MD, US
Michael R. Elashoff - Gaithersburg MD, US
Mark W. Porter - Gaithersburg MD, US
Kory R. Johnson - Gaithersburg MD, US
Brandon Higgs - Gaithersburg MD, US
Arthur L. Castle - Gaithersburg MD, US
Michael Orr - Gaithersburg MD, US
Michael R. Elashoff - Gaithersburg MD, US
Assignee:
Ocimum Biosolutions, Inc. - Indianapolis IN
International Classification:
G06F 19/00
US Classification:
702 19, 435 6, 700 30, 702 22, 7071041
Abstract:
The present invention is based on the elucidation of the global changes in gene expression and the identification of toxicity markers in tissues or cells exposed to a known toxin. The genes may be used as toxicity markers in drug screening and toxicity assays. The invention includes a database of genes characterized by toxin-induced differential expression that is designed for use with microarrays and other solid-phase probes.
Rna Purification Methods
US Patent:
2004018, Sep 16, 2004
Filed:
May 7, 2004
Appl. No.:
10/479724
Inventors:
Michael Orr - Gaithersburg MD, US
Daniel Bednarik - Gaithersburg MD, US
Daniel Wilson - Gaithersburg MD, US
Daniel Bednarik - Gaithersburg MD, US
Daniel Wilson - Gaithersburg MD, US
International Classification:
C07H021/02
US Classification:
536/025400
Abstract:
Methods for the preparation and isolation of high quality RNA are described. The methods do not require lysis of red blood cells and may be used to isolate high quality RNA from cells such as epithelial cells, fibroblasts, bone marrow progenitors, brain tissue or brain cells. The present invention is also directed to kits for practicing the disclosed high quality RNA isolation methods.